Wound closure products are designed to join the exposed edges of a wound together, which helps in faster healing of wound. These products prevent blood loss, reduce recovery time and provide prevention from infectious agents. The various types of wound closure products include sutures, hemostats, surgical staples, adhesive and tissue sealants, and wound closure strips. These are commonly used for the treatment of lacerations, injuries and to treat surgical and chronic wounds during and after surgical procedures.
Wound closure products are sterile in nature, which prevents contamination of wounds during the course of treatment. They also prevent wound dehiscence and gap formation to accelerate wound healing process. These products are used in various internal surgical procedures, such as bariatric surgery, neurosurgical procedures, cardio surgery, orthopedic surgery, gynecology surgery, and ophthalmic surgery. Further, wound closure products help in the treatment of minor injuries which occur during sports or road accidents, and cuts made by sharp instruments.
The products are also used to decrease the dead space and reduce incidence rates of hematoma and seroma, which results in better wound closure. For instance, fibrin sealants and sutures are used to secure skin graft over burnt surface. As a result, contact between skin graft and burnt tissue is decreased, leading to faster healing.
Wound closure products are used for treatment of skin ulcers along with other treatments. Various wound closure products are utilized in combination to achieve benefits of both products. For instance, sutures are coated with tissue sealants to achieve better therapeutic efficacy.
Wound closure products are available in both absorbable and non-absorbable forms for wound closure. Absorbable wound closure products are assimilated by the body and non-absorbable wound closure products are removed after utilization. Absorbable wound closure products reduce the scarring of the tissue produced during the healing process. Various synthetic materials, such as nylon, prolene, medical grade steel, polyester, chromium and titanium alloys, are used for their manufacturing. Also, biomaterial, such as fibrin, collagen, gelatin and thrombin are used for manufacturing of these wound closure products.
On the basis of type, the global wound closure products market has been segmented into sutures, hemostats, surgical staples, adhesive and tissue sealants, and wound closure strips. Suture segment comprises absorbable and non-absorbable sutures. Hemostats segment comprises thrombin-based, oxidized regenerated cellulose-based, combination-based, gelatin-based and collagen-based hemostats. Adhesive and tissue sealants segment comprise fibrin, collagen-based, cyanoacrylate-based, synthetic polymer-based, and albumin and glutaraldehyde-based adhesive and tissue sealants.
On the basis of application, the global wound closure products market has been segmented into cardiovascular surgery, general surgery, gynecological surgery, orthopedic surgery, ophthalmic surgery, and others.
The global wound closure products market was valued at $9,517.1 million in 2015, and it is expected to grow at a CAGR of 6.3% during the period 2016 – 2022. The wound closure products market is growing due to increasing geriatric population, increase in volume of surgeries and growing road accident cases across the globe.
Some of the key companies operating in the global wound closure products market include 3M Company, Medtronic plc, Smith and Nephew plc, CryoLife Inc., DeRoyal Industries Inc., Pfizer Inc., Derma Sciences Inc., Johnson and Johnson, B. Braun Melsungen AG and Baxter International Inc.
Request a sample of this report here: https://www.psmarketresearch.com/market-analysis/wound-closure-products-market/report-sample
